Platelet Rich Plasma Market Robust pace of Industry during -2031Posted by Aparna P on August 29th, 2022  Plasma refers to the liquid portion of one’s blood, in which vitamins, white and red blood cells, and salts are found. Most of the content of plasma comprises water. The plasma turns yellow in color, once red blood cells are removed from it. The global platelet rich plasma market is driven by the growing incidences of bone-related disorders and arthritis. According to the US Arthritis Foundation, arthritis is one of the leading reasons for adult disability in the nation.
In October 2017, Stryker Corporation announced about its acquisition of Vexim The latter is a France-based company. The French company is a manufacturer of medical devices and specializes in minimally invasive treatment. With this acquisition, that Stryker Corporation will be able to expand its geographical reach.
DOWNLOAD A BROCHURE OF THE LATEST RESEARCH REPORT
Some of the key market players of the global platelet rich plasma market are
Harvest Technologies Corporation
Cesca Therapeutics, Inc.
Stryker Corporation
EmCyte Corporation
Zimmer Biomet
Nuo Therapeutics, Inc.
About TMR Research:
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.
Like it? Share it! More by this author |